Fraunhofer Health

Health research at Fraunhofer addresses the four key areas of medical science — drugs, diagnostics, devices and data, or 4D for short. Many innovations emerge at the interface between medical science, natural science, computer science and engineering. With its emphasis on transdisciplinary research, the Fraunhofer-Gesellschaft offers the perfect environment for close collaboration on health research and the development of cost-intelligent precision medicine for the benefit of patients.



Fraunhofer Institute for Biomedical Engineering IBMT

Bidirectional control of prosthetic hands using ultrasonic sensors

For anyone who has lost a hand, a functional prosthetic hand is of enormous benefit when it comes to everyday activities. So researchers at Fraunhofer are working as part of an EU research project to improve control of prosthetic hands down to individual fingers. Instead of conventional electrodes that detect nerve impulses in muscle tissue in the arm, these rely on ultrasonic sensors. This means commands can be executed with far greater accuracy and sensitivity. In the next stage, researchers want to make the design bidirec-tional, with the brain also receiving sensory stimuli from the prosthesis.


Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Fraunhofer, DESY, Hereon and EMBL sign MoU for closer collaboration.

Fraunhofer ITMP participates in the health area and already brought this cooperation to life with the »Fraunhofer at DESY: Focus on BioMed« workshop on November 9th 2023. The joint proposal on »The role of antibiotic influx and efflux in antimicrobial resistance of Gram-negative bacteria« from ITMP (experiment design, probes), IAP-CAN (nanoparticle markers) and DESY (imaging) has been awarded as one of the pilot projects.


Fraunhofer Institute for Digital Medicine MEVIS

Bremen AI in Health conference: science, business and politics exchanged ideas on AI and health research

More than 150 stakeholders from science, business and politics met at the Bremen AI in Health conference on September, 21 2023 to discuss artificial intelligence and health research.


Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Why does the environmental risk assessment for drugs need to be updated?

Drugs that are to be marketed in Europe must always be approved by the competent authority. For over 15 years, the environmental risk assessment (ERA) has been a mandatory part of the application for approval. The ERA systematically identifies risks of environmental damage. The aim of an ERA is to ensure that the drug manufacturer understands the possible environmental risks — such as impacts on drinking water and aquatic ecosystems, antibiotic resistance, adverse effects on microorganisms and other environmental interactions — and takes appropriate steps to minimize these risks.


Publication | Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Inverser Impfstoff stoppt Gewebedestruktion im Tiermodell

Inverse Impfstoffe sollen Immunreaktionen löschen, statt induzieren. Einen solchen Toleranz-erzeugenden Impfstoff gegen eine Autoimmunreaktion bei rheumatoider Arthritis hat eine internationale Forschungsgruppe vorgestellt – inklusive erster Erfolge bei Mäusen.


Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Topping-out ceremony of the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP


5th International Conference at Fraunhofer IMTE in Lübeck

3D Printing in Medicine

Additive Manufacturing Meets Medicine AMMM 2023 – the 5th annual scientific meeting on 3D printing in medicine attracted international attention.


panel discussion Asklepios Campus Hamburg

Welche Rolle spielt Künstliche Intelligenz für die Zukunft der medizinischen Lehre?

Am 05.09.2023 fand die vom Asklepios Campus Hamburg der Semmelweis Universität (ACH) veranstaltete Podiumsdiskussion zum Thema "Wie viel Künstliche Intelligenz (KI) im Medizin-Lehrplan? Positionen und Perspektiven zu KI im Medizinstudium" hoch über Hamburgs Dächern in der Sturmfreien Bude statt. Auf Einladung von Gastgeber Dr. Thorsten Thiel, Geschäftsführer der Asklepios Medical School GmbH, diskutierten führende Expert:innen relevanter Fachgebiete vor einem interessierten Publikum ihre Erkenntnisse und Thesen zum Einfluss von KI auf die medizinische Bildung.


Fraunhofer Institute for Digital Medicine MEVIS

With the heart into the world – Cardio expert Hindricks visits Fraunhofer MEVIS

In an engaging lecture by the cardio expert and professor Gerhard Hindricks on August 30th, approximately 70 attendees simultaneously gained insights into pioneering approaches in cardiac medicine and into the possible routes toward securing healthcare in remote or underserved regions. Because those who deal with cardiovascular diseases cannot avoid taking a global epidemiological perspective: Diseases of the heart and vessels are the leading cause of death globally and affect various geographical locations, age groups, and socioeconomic structures.


Fraunhofer Institute for Biomedical Engineering IBMT

Development and validation of a software platform for the prevention, detection and analysis of cyberattacks in the healthcare sector

In the EU project »AI4HealthSec«, an international team of researchers aims to provide operators of health information infrastructures with innovative software tools to improve the detection and analysis of cyberattacks and threats and thus, to increase the security of health information infrastructures. For this purpose, the project will develop and validate the so-called AI4HealthSec platform. The Fraunhofer Institute for Biomedical Engineering IBMT is contributing its many years of expertise in the development of innovative health information systems and their validation to the project. It provides three of its systems as examples to test the AI4HealthSec platform.


Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses IZI-BB

switchSENSE technology for quantitative determination of virus-receptor binding

How strongly do SARS-CoV-2 viruses bind to the hACE2 receptor?


Fraunhofer Center for Digital Diagnostics ZDD

Identifying needs - shaping transformation

Die Digitalisierung hält für die Verbesserung des Gesundheitssystems noch Trümpfe im Ärmel, die sogar den Fachkräftemangel und die bedenkliche Versorgung in ländlichen Gebieten etwas abmildern könnten. Das Fraunhofer-Zentrum für Digitale Diagnostik – eine von Bund und dem Land Brandenburg geförderte Initiative – hat sich zum Ziel gesetzt, dafür nachhaltige Lösungen zu entwickeln, die heutige und zukünftige digitale Möglichkeiten ausschöpfen. Das Flächenland Brandenburg dient dafür als Modellregion.


Fraunhofer Institute for Cell Therapy and Immunology IZI

State government of Mecklenburg-Vorpommern supports research into extracorporeal therapy systems

In close cooperation with the Rostock University Medical Center and various academic and industrial partners, the Fraunhofer Institute for Cell Therapy and Immunology IZI is conducting intensive research on extracorporeal therapy systems.


Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Smart health: ensuring data privacy by providing comprehensive anonymization processes

Project »PrivacyUmbrella«. Thanks to the constant development of communication technology, such as portable mobile devices and wearables, the concept of “smart health” - and with it the continuous improvement of personal health - has become an essential element of modern life for many people. Through the constant collection of data, smart health can promote a healthier lifestyle and also be used to identify possible issues. 



News Archive

Further notifications from our member institutes